These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20092352)

  • 1. Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2.
    Flagler MJ; Mahajan SS; Kulkarni AA; Iyer SS; Weiss AA
    Biochemistry; 2010 Mar; 49(8):1649-57. PubMed ID: 20092352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of Pk-trisaccharide analogs of globotriaosylceramide to Shiga toxin variants.
    Yosief HO; Iyer SS; Weiss AA
    Infect Immun; 2013 Aug; 81(8):2753-60. PubMed ID: 23690406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinities of Shiga toxins 1 and 2 for univalent and oligovalent Pk-trisaccharide analogs measured by electrospray ionization mass spectrometry.
    Kitova EN; Kitov PI; Paszkiewicz E; Kim J; Mulvey GL; Armstrong GD; Bundle DR; Klassen JS
    Glycobiology; 2007 Oct; 17(10):1127-37. PubMed ID: 17686801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
    Szymczak-Kulus K; Weidler S; Bereznicka A; Mikolajczyk K; Kaczmarek R; Bednarz B; Zhang T; Urbaniak A; Olczak M; Park EY; Majorczyk E; Kapczynska K; Lukasiewicz J; Wuhrer M; Unverzagt C; Czerwinski M
    J Biol Chem; 2021; 296():100299. PubMed ID: 33460651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga toxin binding to glycolipids and glycans.
    Gallegos KM; Conrady DG; Karve SS; Gunasekera TS; Herr AB; Weiss AA
    PLoS One; 2012; 7(2):e30368. PubMed ID: 22348006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues.
    Watanabe M; Igai K; Matsuoka K; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    Infect Immun; 2006 Mar; 74(3):1984-8. PubMed ID: 16495579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shiga toxin-binding site for host cell receptor GPP130 reveals unexpected divergence in toxin-trafficking mechanisms.
    Mukhopadhyay S; Redler B; Linstedt AD
    Mol Biol Cell; 2013 Aug; 24(15):2311-8. PubMed ID: 23761068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro assessment of a chemically synthesized Shiga toxin receptor analog attached to chromosorb P (Synsorb Pk) as a specific absorbing agent of Shiga toxin 1 and 2.
    Takeda T; Yoshino K; Adachi E; Sato Y; Yamagata K
    Microbiol Immunol; 1999; 43(4):331-7. PubMed ID: 10385199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 13C4 monoclonal antibody that neutralizes Shiga toxin Type 1 (Stx1) recognizes three regions on the Stx1 B subunit and prevents Stx1 from binding to its eukaryotic receptor globotriaosylceramide.
    Smith MJ; Carvalho HM; Melton-Celsa AR; O'Brien AD
    Infect Immun; 2006 Dec; 74(12):6992-8. PubMed ID: 17030576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance.
    Nakajima H; Kiyokawa N; Katagiri YU; Taguchi T; Suzuki T; Sekino T; Mimori K; Ebata T; Saito M; Nakao H; Takeda T; Fujimoto J
    J Biol Chem; 2001 Nov; 276(46):42915-22. PubMed ID: 11557760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga-like toxin binds with high avidity to multivalent O-linked blood group P1 determinants on mucin-type fusion proteins.
    Maria Cherian R; Gaunitz S; Nilsson A; Liu J; Karlsson NG; Holgersson J
    Glycobiology; 2014 Jan; 24(1):26-38. PubMed ID: 24082034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembled monolayers of globotriaosylceramide (Gb3) mimics: surface-specific affinity with shiga toxins.
    Miura Y; Sasao Y; Dohi H; Nishida Y; Kobayashi K
    Anal Biochem; 2002 Nov; 310(1):27-35. PubMed ID: 12413469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2.
    Kulkarni AA; Fuller C; Korman H; Weiss AA; Iyer SS
    Bioconjug Chem; 2010 Aug; 21(8):1486-93. PubMed ID: 20669970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes.
    Winter KR; Stoffregen WC; Dean-Nystrom EA
    Infect Immun; 2004 Nov; 72(11):6680-4. PubMed ID: 15501802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivalent inhibition of AB(5) toxins.
    Gargano JM; Ngo T; Kim JY; Acheson DW; Lees WJ
    J Am Chem Soc; 2001 Dec; 123(51):12909-10. PubMed ID: 11749553
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in Ribosome Binding and Sarcin/Ricin Loop Depurination by Shiga and Ricin Holotoxins.
    Li XP; Tumer NE
    Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28398250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogenetic analysis of Shiga toxin 1 and Shiga toxin 2 genes associated with disease outbreaks.
    Lee JE; Reed J; Shields MS; Spiegel KM; Farrell LD; Sheridan PP
    BMC Microbiol; 2007 Dec; 7():109. PubMed ID: 18053224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide.
    Itoh K; Tezuka T; Inoue K; Tada H; Suzuki T
    Tohoku J Exp Med; 2001 Dec; 195(4):237-43. PubMed ID: 11908825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells.
    Marcato P; Mulvey G; Armstrong GD
    Infect Immun; 2002 Mar; 70(3):1279-86. PubMed ID: 11854211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.